Gigantic global markets
100 billion global market in 2030 is estimated, attracting drug developeres to develop better obesity drugs
With a bold vision to become a global leader in resistance-targeted therapeutics, we are pioneering curative solutions for drug-resistant, immunotherapy-refractory cancers and incurable viral threats, the areas of highest mortality and unmet need.